Coronavirus Vaccine Update: Positive Development For Indian COVID-19 Vaccine, Moderna Moves To Second Phase Testing

COVID-19: Status of vaccine development

It has officially been more than six months since the COVID-19 pandemic, since it started to spread.

According to the latest figures, the infection cases have breached the 6 million mark, with 1,98,700 cases reported out of India alone.

The rising number of cases across the world have paved the way for speedy clinical trials as the hunt for an effective vaccine or cure continues. Experts still suggest that it could take anywhere between 12-16 months for the world to get a ready vaccine to counter the virus. Even so, more than 110 groups around the world are in contention to manufacture a vaccine right now. Some have advanced to the second phase, while others are experimenting with alternative medicines. We give you an update on the latest round of development of the most promising vaccines right now.

US-based Moderna Therapeutic's innovative messenger RNA-1273 prototype is being seen as one of the most promising contenders globally. The pharma group has proceeded to conduct stage 2 of the clinical trials and has started dosing patients accordingly, a statement released by the company said. In the second phase of its trial and plans to enrol around 600 more patients moving forward.